Covariate modeling in pharmacometrics: General points for consideration
CPT: Pharmacometrics & Systems Pharmacology · 2024-05 · 13 (5) · 710-728
DOI: 10.1002/psp4.13115 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 02.04.2024. Verfasst von Kinjal Sanghavi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology, Genmab US, Inc., Princeton, New Jersey, USA. Hauptthemen laut MEDLINE: Models, Statistical. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Modeling the relationships between covariates and pharmacometric model parameters is a central feature of pharmacometric analyses. The information obtained from covariate modeling may be used for dose selection, dose individualization, or the planning of clinical studies in different population subgroups. The pharmacometric literature has amassed a diverse, complex, and evolving collection of methodologies and interpretive guidance related to covariate modeling. With the number and complexity of technologies increasing, a need for an overview of the state of the art has emerged. In this article the International Society of Pharmacometrics (ISoP) Standards and Best Practices Committee presents perspectives on best practices for planning, executing, reporting, and interpreting covariate analyses to guide pharmacometrics decision making in academic, industry, and regulatory settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Clinical Pharmacology, Genmab US, Inc., Princeton, New Jersey, USA.
- Pharmetheus AB, Uppsala, Sweden.
- Metrum Research Group, Tariffville, Connecticut, USA.
- Quantitative Clinical Pharmacology, Takeda Pharmaceutical, Cambridge, Massachusetts, USA.
- Department of Pharmacy, Uppsala University, Uppsala, Sweden.
- Department of Pharmacology & Clinical Pharmacology, University of Auckland, Auckland, New Zealand.
ORCID-Profile: James A Rogers, Mariam A Ahmed, Mats O Karlsson, Nick Holford, Essam Kerwash, Justin J Wilkins
Zitieren
APA
Sanghavi, K., Ribbing, J., Rogers, J. A., Ahmed, M. A., Karlsson, M. O., Holford, N., Chasseloup, E., Ahamadi, M., Kowalski, K. G., Cole, S., Kerwash, E., Wade, J. R., Liu, C., Wang, Y., Trame, M. N., Zhu, H., Wilkins, J. J., & ISoP Standards & Best Practices Committee (2024). Covariate modeling in pharmacometrics: General points for consideration. CPT: Pharmacometrics & Systems Pharmacology, 13(5), 710-728. https://doi.org/10.1002/psp4.13115
Vancouver
Sanghavi K, Ribbing J, Rogers JA, Ahmed MA, Karlsson MO, Holford N, et al. Covariate modeling in pharmacometrics: General points for consideration. CPT: Pharmacometrics & Systems Pharmacology. 2024;13(5):710-728. doi:10.1002/psp4.13115
BibTeX
@article{Sanghavi2024,
author = {Sanghavi, Kinjal and Ribbing, Jakob and Rogers, James A and Ahmed, Mariam A and Karlsson, Mats O and Holford, Nick and Chasseloup, Estelle and Ahamadi, Malidi and Kowalski, Kenneth G and Cole, Susan and Kerwash, Essam and Wade, Janet R and Liu, Chao and Wang, Yaning and Trame, Mirjam N and Zhu, Hao and Wilkins, Justin J and ISoP Standards & Best Practices Committee, ISoP Standards & Best Practices Committee},
title = {Covariate modeling in pharmacometrics: General points for consideration},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2024},
volume = {13},
number = {5},
pages = {710--728},
doi = {10.1002/psp4.13115}
}
EUVIMED